Introduction
============

Gastric cancer remains one of the most frequently occurring malignancies, and ranks as the second leading cause of mortality next to lung cancer [@B1]. Although alterations in a large number of oncogenes and tumor suppressor genes have been reported in gastric carcinomas [@B2], the molecular mechanisms underlying the pathogenesis of gastric carcinomas remain to be fully defined.

miRNAs are small, noncoding, single-stranded RNAs that bind to complementary sequences in the 3\' untranslated region (UTR) of their target mRNAs and induce mRNA degradation or translational repression [@B3]. miRNAs are involved in various cell functions, including proliferation, differentiation and apoptosis. Characteristic miRNA signatures have been identified for human gastric cancer, which predict disease status and clinical outcome [@B4]-[@B9]. Among them, miR-148a was one of the most frequently downregulated miRNAs in miRNA profiles of gastric cancers [@B4], [@B7], [@B8], and correlated with tumor size [@B9] and node metastasis [@B7]. Previous studies have shown that miR-148a plays important roles in cancer cell proliferation, response to anti-cancer chemotherapy, and metastasis in some tumor types including cholangiocarcinoma, prostate, esophageal and colon cancers [@B10]-[@B15]. For instance, downregulation of cytokine interleukin-6-regualted miR-148a contributes to cell proliferation by its target DNMT1 in malignant cholangiocytes [@B10]. In prostate cancer PC3 cells, miR-148a could inhibit cell proliferation, migration and invasion, and increase the sensitivity to anti-cancer drug [@B11]. However, the functional roles and target genes of miR-148a in gastric cancer remain unknown.

In this study, we investigated the role of miR-148a in cell proliferation of gastric cancer cells. Unexpectedly, inhibition of miR-148a expression repressed cell proliferation in gastric cancer cell lines. Conversely, transient and stable overexpression of miR-148a promoted cell proliferation and cell cycle progression. Moreover, p27, a key inhibitor of cell cycle, was identified as the direct target of miR-148a, suggesting that miR-148a might exert its function through the downregulation of p27. Finally, we confirmed that miR-148a expression was frequently downregulated in human advanced gastric cancer tissues, and observed a good inverse correlation between miR-148a and p27 expression in tumor samples. Taken together, our findings suggested that miR-148a downregulation might exert antagonistic function in gastric cancer cell proliferation during gastric tumorigenesis.

Results and Discussion
======================

To explore the tissue-specific expression pattern of miR-148a, we detected miR-148a expression in different tissues of mouse by Northern blot. miR-148a expression was relatively high in stomach, heart, intestine, colon and liver (Fig. [1](#F1){ref-type="fig"}A). To visualize the spatial localization of miR-148a in whole-stomach tissue of mouse, we applied locked nucleic acid in situ hybridization. Unlike with the mismatch control probe (scrambled miRNA), hybridization with miR-148a-specific probe revealed that miR-148a was expressed at the bottom half of glandular gastric epithelium, where parietal and chief cells resided (Fig. [1](#F1){ref-type="fig"}B).

Several independent lines of evidence have shown that miR-148a was one of the most frequently downregulated microRNAs in human gastric carcinomas [@B4], [@B7], [@B8]. These studies led us to speculate that miR-148a dowregulation could contribute to gastric cell proliferation. We first detected miR-148a expression in 6 human gastric cancer cell lines. Northern blot results showed that miR-148a expression in AGS, BGC-823 and SGC-7901 cells was relatively higher than that in GES-1, BGC-803 and SNU-16 cells (Fig. [2](#F2){ref-type="fig"}A). Next, to evaluate the role of miR-148a downregulation in gastric cancer cells, we engineered miR-148a with antisense oligonucleotides (miR-148a AS) to decrease the endogenous miR-148a expression in 3 human gastric cancer cell lines, AGS, BGC-823 and SGC-7901, respectively. The downregulation of miR-148a were confirmed by Northern Blot (Fig. [2](#F2){ref-type="fig"}B). Cellular proliferation assays were performed on the miR-148a-AS-tranfected cells. To our surprise, miR-148a knockdown inhibited cell proliferation by 20-40% after 96 hours in AGS, BGC-823, and SGC-7901 cells (Fig. [2](#F2){ref-type="fig"}C, p\<0.05).

To substantiate the function of miR-148a in gastric cell proliferation, we transfected AGS cells with miR-148a mimic. Northern Blot confirmed the increased expression of miR-148a in the transfectant (Fig. [2](#F2){ref-type="fig"}D). Viable cell numbers were counted at 72 and 96 hours after transfection. Consistent with our prediction, the cell numbers of miR-148a-transfected AGS cells at 72 and 96 hours were found to be increased by 42% and 48%, respectively, compared with that of scrambled-miRNA-transfected cells (Fig. [2](#F2){ref-type="fig"}D, p\<0.05). Moreover, we established a stable cell line (AGS-miR-148a) in which miR-148a expression was significantly higher than that in AGS stably transfected with empty vector (AGS-vector) (Fig. [2](#F2){ref-type="fig"}E). Consistently, the cell numbers of AGS-miR-148a at 48 and 72 hours were increased by 18% and 30%, respectively, compared with that in control cells (Fig. [2](#F2){ref-type="fig"}E, p\<0.05).

It is known that abnormal cell proliferation is related to the altered cell cycle. Cell cycle analysis was conducted in AGS cells transiently transfected with miR-148a mimic. The proportion of cells corresponding to S phase was higher in miR-148a-transfected AGS (34%±2.9%) than that in control cells (26%±2.1%, p\<0.05, Fig. [2](#F2){ref-type="fig"}F). Similar results were obtained in the stable miR-148a-expressing AGS cells (Fig. [2](#F2){ref-type="fig"}G). These data suggested that miR-148a could promote cell proliferation by increasing the population of cells in S phase. In addition, we checked the effect of miR-148a on apoptosis by FACS analysis, and no obvious differences were observed between miR-148a-tansfected AGS cells and control cells (Fig. [2](#F2){ref-type="fig"}H).

To determine the mechanisms by which miR-148a promotes gastric cell proliferation, bioinformatics analysis was performed to search for miR-148a targets. CDNK1B (encoding p27), a gene critical for cell cycle [@B15], was predicted as a putative target of miR-148a (Fig. [3](#F3){ref-type="fig"}A). p27 mRNA 3\'UTR has a single predicted binding site that is highly conserved in mammals, and in chicken (Fig. [3](#F3){ref-type="fig"}A). To determine whether miR-148a could directly regulate p27, p27 mRNA 3\'UTR encompassing the predicted binding site with or without mutation that would disrupt miRNA interaction (underlined in Fig. [3](#F3){ref-type="fig"}A), were inserted to the downstream of luciferase open reading frame in pGL3-CM reporter vector. When introduced into SGC-7901 cells, the wild type p27 3\'UTR reporter showed a 39% reduction in luciferase activity in the miR-148a-transfected cells compared with that in scrambled-miRNA-transfected cells (Fig. [3](#F3){ref-type="fig"}B, p\<0.01). Mutation of miR-148a binding site abrogated the repression of luciferase activity caused by miR-148a overexpression (Fig. [3](#F3){ref-type="fig"}B). Next, we pursued the ability of miR-148a to regulate the expression of endongenous p27. miR-148a overexpression with mimic in AGS cells dramatically repressed p27 expression (Fig. [3](#F3){ref-type="fig"}C). Conversely, miR-148a knockdown by AS dramatically enhanced p27 expression in BGC-823 cells (Fig. [3](#F3){ref-type="fig"}C), indicating that endogenous miR-148a could regulate p27 abundance. To examine the functional interrelationship between miR-148a and p27, AGS cells was simultaneously transfected with miR-148a mimic and p27-expressing vector (CMV-p27). As expected, overexpression of p27 dramatically rescued miR-148a-induced growth promotion (Fig. [3](#F3){ref-type="fig"}D, p\<0.01), indicating that miR-148a enhanced cell proliferation possibly by repressing p27.

Finally, we detected the expression of miR-148a and p27 in 10 advanced gastric primary tumors, each one paired with adjacent nontumor gastric tissue from the same patient (Fig. [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}C). Northern blot assays showed that the reduced expression of miR-148a was found in 100% (10/10) of human advanced gastric tumor tissues as compared with adjacent normal counterparts (Fig. [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B, p=0.005), indicating that miR-148a downregulation was a very common event in advanced gastric cancer. Furthermore, the inverse correlation was observed between miR-148a and p27 in tumor samples (r=0.648, Fig. [4](#F4){ref-type="fig"}D), suggesting that miR-148a could negatively regulate p27 expression in human gastric cancer.

Previous studies have shown that miR-148a could target its distinct targets to regulate cell proliferation in some cancer cells [@B10],[@B12],[@B16]. DNMT1, a direct target of miR-148a, plays important role to suppress cell proliferation in malignant cholangiocytes [@B10]. miR-148a, also targets and suppresses Microphthalmia associated transcription factor (Mitf), an important regulator involved in melanoma progression [@B16]. In the present study, we identified a new target, p27, possibly by which miR-148a could promote cell cycle progression and cell proliferation. Similarly, miR-148a could promote cell growth by repressing its target CAND1 expression in prostate cancer LNCaP cells [@B12]. These findings indicated that the different roles of miR-148a in regulating cell proliferation might depend on its distinct targets in different tumor cell types. miR-148b, which has the same "seed sequence" as miR-148a, was downregulated in gastric cancer, and could inhibit cell proliferation by targeting CCKBR [@B17]. Although CCKBR was a predicted target of miR-148a by bioinformatic analysis, it was not a real target of miR-148a by Western blot and luciferase reporter assay in our experimental system (data not shown), indicating that miR-148a and miR-148b, both belonging to the same microRNA family, might exert opposite roles in one cell type possibly by regulating distinct targets.

In this study, we observed that miR-148a was frequently downregulated in human advanced gastric cancer samples. We also showed that inhibition of miR-148a suppressed cell proliferation in different gastric cancer cell lines possibly by upregulating its target p27, suggesting that miR-148a downregulation in human gastric cancer might inhibit but not promote gastric cancer cell proliferation during gastric tumorigenesis. Some evidence has shown that miR-148a is associated with migration, metastasis, and drug resistance in some tumor types [@B7],[@B11],[@B13],[@B14], indicating that miR-148a downregulation might contribute to these biological processes in gastric cancer. In fact, we also found that miR-148a overexpression with mimic could promote gastric cell migration (Fig. [S1](#FS1){ref-type="fig"}, p\<0.05).

Conclusion
==========

In this study, we investigated the role of miR-148a in regulating cell proliferation of gastric cancer cells. We observed that miR-148a expression was frequently and dramatically downregulated in human advanced gastric cancer tissues compared with the matched adjacent normal tissues. Unexpectedly, miR-148a knockdown inhibited cell proliferation in gastric cancer cell lines. We further showed that transient and stable overexpression of miR-148a could promote cell proliferation and cell cycle progression. Moreover, p27, a key inhibitor of cell cycle, was verified as a direct target of miR-148a, suggesting that miR-148a might promote gastric cell proliferation by depressing p27 expression. Collectively, our findings indicated that miR-148a downregulation might exert some sort of antagonistic function in gastric cancer cell proliferation during gastric tumorigenesis.

Methods
=======

*Human gastric tissues.* Paired gastric cancer and adjacent non-tumor gastric tissues were obtained after review and approval by the General Surgery Department of PLA General Hospital of China. Both tumor and non-tumor tissues were histologically confirmed. Informed consent was obtained from each patient before operation. Tissue samples were immediately frozen in liquid nitrogen until RNA extraction.

*Cell culture and transfection.* The gastric cancer cell lines AGS, GES-1, SNU-16, MGC-803, BGC-823 and SGC-7901 were cultured in Dulbecco\'s Modified Eagle Medium supplemented with 2mM L-glutamine, 1% penicillin/streptomycin, and 10% fetal bovine serum (Hyclone) at 37℃ and 5% CO~2~. AGS, BGC-823 and SGC-7901 cells were individually plated onto tissue culture plates or dishes 24 hours before transfection. Transient transfection of miRNA mimics or anti-sense (AS) and control oligonucleotides (Genepharm) at a final concentration of 50 nM was accomplished with lipofectmine 2000 reagent (Invitrogen). To establish stably transfected AGS, pIRES2-EGFP vector (BD Bioscience) was inserted with 164bp genomic sequence of miR-148a precursor. The primers for PCR amplification are: sense, 5\'- AAAAGATCTGAACACACCTGCAGGAAGAA-3\', anti-sense, 5\'- AAAAAAGCTTCTGGCGTCTGGAGCACTG-3\'. Stably transfected cells were selected using G418 (500μg/ml, Gibco).

*Cell cycle analysis.* Cells were harvested and processed by standard methods by using propidium iodide staining of cell DNA. Cell samples were analyzed with a FACScan flow cytometer (BD Biosciences). Histograms were analyzed for cell cycle compartments using ModFit version 2.0 (Verity Software House).

*Proliferation assays.* 2×10^4^ Cells were seeded into 24-well plate in triplicate, and the cell number was counted 48, 72 or 96 hours later under microscope using a hemocytometer.

*Apoptosis assay.*AGS cells were treated with etoposide (30μg/ml) or a matched concentration of diluents for 48 hours. After the treatment, cells were rinsed twice in cold PBS, and then analyzed for apoptosis by a PE-labeled Annexin-V/7-AAD assay. Cell samples (10,000 events) were analysed in a FACScan flow cytometer (BD Biosciences), and data were processed using FACScan software.

*Luciferase activity assay.*The 3\'UTR region of human p27 mRNA that containing miR-148a target site was amplified using specific primers: sense, 5\'- CCGCTCGAGGTTTATCAGATACATCACTGCTTGA-3\', anti-sense, 5\'- CCGACGCGTTTGGCTCAGTATGCAACCTTTT-3\', and cloned into pGL3-CM to generate luciferase reporter vector. The mutant vector of p27 3′UTR was also constructed. The method for luciferase assay was described previously [@B18]. In brief, reporter vectors were co-transfected with renilla luciferase expressing vector to normalize transfection efficiency. Luciferase activity assays were done at 48 hours after transfection using a Dural-luciferase® reporter assay system (promega) using LB 960 Centro XS3 luminometer (Berthold Technologies).

*Northern blot.* Northern blot analysis was performed as described using 20 μg total RNA from each sample [@B18]. Probes were labeled with 32P γ-ATP using T4 polynucleotide kinase (New England Biolabs).

*miRNA in situ hybridization.*miRNA in situ hybridization was performed as previously described [@B19] using locked nucleic acid (LNA) probes complementary to mouse mature miR-148a (Exiqon) or scrambled control sequence (Exiqon). LNA probes were hybridized to mouse gastric tissue at 60°C.

*Western blot.* Cells were homogenized in lysis buffer supplemented with protease inhibitor cocktail (Roche). Proteins (25 ug) were electrophoresed on SDS-PAGE and transferred onto PVDF membranes. Immunoblotting was done using human p27 (Cell Signaling) and GAPDH (ZSGB-Bio) antibodys.

*Statistical analysis.* All values were expressed as mean±SD. Statistical analysis was performed by 2-tailed Student\'s *t*test, and results were considered statistically significant at *P*\< 0.05. Wilcoxon signed rank test was used to analyze the statistically significant downregulation of miR-148a expression in gastric cancers. Correlation coefficient was calculated by Spearman rank correlation analysis.
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![Tissue-specific and cell-specific expression pattern of miR-148a in mouse (**A**), miR-148a expression was detected in various tissues of mouse by Northern blot. (**B**), ISH analysis showed that miR-148a expression was located at bottom half of gastric epithelium in mouse. Original magnification, ×200.](ijbsv07p0567g01){#F1}

![miR-148a promoted cell proliferation in gastric cancer cells. (**A**), miR-148a expression was measured by Northern blot in 6 human gastric cancer cell lines. (**B**), miR-148a downregulation with AS was confirmed by Northern Blot in a representative transfectant. (**C**), miR-148a downregulation inhibited cell proliferation in AGS, BGC-823 and SGC-7901 cells. Gastric cancer cells were transfected with miR-148a AS or scrambled miRNA AS (as a negative-control, NC AS). Cell viability was determined by cell count 72 and 96 hours after transfection. The numbers of viable cells transfected with NC AS were set at 1. (**D**), miR-148a promoted cell proliferation in AGS cells. miR-148a overexpression with mimic were confirmed by Northern Blot in AGS cells. Cell viability was determined by cell count 72 and 96 hours after transfection. (**E**), Northern blot revealed that miR-148a expression was increased in stably miR-148a-expressing AGS cells (miR-148a) compared with AGS stably transfected with empty vector (vector). Cell count showed that the cell numbers at 48 and 72 hours were increased in stably miR-148a-expressing AGS cells. (**F**), Cell cycle analysis showed that AGS cells transiently transfected with miR-148a mimic exhibited increased population of cells at S phase 24 hours after transfection. (**G**), Stably miR-148a-expressing AGS cells (AGS-miR-148a) also showed increased population of cells at S phase. (**H**), FCAS analysis showed no obvious change was observed in apoptosis induced by Etoposide. Values represent mean ± SD. n=3. \*P\<0.05, \*\*P\<0.01.](ijbsv07p0567g02){#F2}

![p27 was a direct target of miR-148a in gastric cancer cells. (A), The possible miR-148a binding site in CDNK1B (p27) mRNA 3\'UTR was predicted by bioinformatic analyses. The mutant seed sequence was underlined. p27 had a single predicted binding site in mRNA 3\'UTR that was highly conserved in mammals, and in chicken (the complementary sequences of seed sequence of miR-148a were highlighted). (B), Luciferase activities were measured in SGC-7901 cells cotransfected with the reporter constructs containing 3\'UTR of p27 with or without mutant (underlined in A) and miR-148a mimic or negative-control miRNA. (C), Western blot assays confirmed that p27 expression were downregulated by miR-148a mimic in AGS cells and upregulated by miR-148a AS in BGC-823 cells. (D), p27 expression was significantly increased in p27-transfected AGC cells (CMV-HA-p27) compared with that in control cells (CMV-HA). The numbers of viable AGS cells were determined by cell count 72 hours after cotransfection with miR-148a mimic and CMV-HA-p27 vector. Values represent mean ± SD. n=3. \*\*P\<0.01](ijbsv07p0567g03){#F3}

![miR-148a was frequently and dramatically downregulated in human advanced gastric cancer and showed an inverse correlation with p27 expression in tumor samples. (**A**), miR-148a expression was determined by Northern blot in 10 advanced gastric primary tumors, each one paired with adjacent nontumor gastric tissue from the same patient. (**B**), Statistically significant downregulation of miR-148a in gastric cancers over matching normal tissues. P=0.005 by Wilcoxon signed rank test. Bars represent mean. (**C**), p27 expression was examined by Western blot in the same samples. (**D**), The relationship between miR-148a and p27 expression was detected by Spearman rank correlation analysis in tumor samples. r=0.648. p\<0.05.](ijbsv07p0567g04){#F4}

![miR-148a promoted gastric cell migration in AGS cells. Scratch wound-healing assay was conducted in miR-148a-transfected AGS cells and control cells. Migration distance was measured at 0, 24, 48 hours after cells were scratched. Values represent mean ± SD. n=3. \*P\<0.05.](ijbsv07p0567g05){#FS1}
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